139
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Elevated Nesfatin-1 Level in Synovium and Synovial Fluid is Associated with Pro-Inflammatory Cytokines in Patients with Rheumatoid Arthritis

, , &
Pages 5269-5278 | Published online: 07 Sep 2021

References

  • Aletaha D, Smolen J. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360–1372. doi:10.1001/jama.2018.13103
  • Smolen J, Aletaha D, McInnes I. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/s0140-6736(16)30173-8
  • Radawski C, Genovese M, Hauber B, et al. Patient perceptions of unmet medical need in rheumatoid arthritis: a cross-sectional survey in the USA. RheumatolTher. 2019;6(3):461–471. doi:10.1007/s40744-019-00168-5
  • Mun S, Lee Y, Park A, et al. Proteomics approach for the discovery of rheumatoid arthritis biomarkers using mass spectrometry. Int J Mol Sci. 2019;20(18):4368. doi:10.3390/ijms20184368
  • Vasileiadis G, Lundell A, Zhang Y, et al. Adipocytokines in untreated newly diagnosed rheumatoid arthritis: association with circulating chemokines and markers of inflammation. Biomolecules. 2021;11(2):325. doi:10.3390/biom11020325
  • Singh A, Gupta M, Mishra S. Study of correlation of level of expression of Wnt signaling pathway inhibitors sclerostin and dickkopf-1 with disease activity and severity in rheumatoid arthritis patients. Drug Discov Ther. 2019;13(1):22–27. doi:10.5582/ddt.2019.01011
  • Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(9):1198–1201. doi:10.1136/ard.2005.046540
  • Seven A, Güzel S, Aslan M, Hamuryudan V. Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int. 2009;29(7):743–747. doi:10.1007/s00296-008-0764-8
  • Migita K, Maeda Y, Miyashita T, et al. The serum levels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006;24:698–701.
  • Oh-I S, Shimizu H, Satoh T, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature. 2006;443(7112):709–712. doi:10.1038/nature05162
  • Wei Y, Li J, Wang H, Wang G. NUCB2/nesfatin-1: expression and functions in the regulation of emotion and stress. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:221–227. doi:10.1016/j.pnpbp.2017.09.024
  • Angelone T, Rocca C, Pasqua T. Nesfatin-1 in cardiovascular orchestration: from bench to bedside. Pharmacoll Res. 2020;156:104766. doi:10.1016/j.phrs.2020.104766
  • Xu Y, Chen F. Antioxidant, anti-inflammatory and anti-apoptotic activities of nesfatin-1: a review. J Inflamm Res. 2020;13:607–617. doi:10.2147/jir.s273446
  • Zhang Y, Shui X, Lian X, Wang G. Serum and synovial fluid nesfatin-1 concentration is associated with radiographic severity of knee osteoarthritis. Med Sci Monitor. 2015;21:1078–1082. doi:10.12659/msm.892875
  • McInnes I, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–442. doi:10.1038/nri2094
  • Feldmann M, Maini S. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev. 2008;223(1):7–19. doi:10.1111/j.1600-065X.2008.00626.x
  • Jiang L, Xu K, Li J, et al. Nesfatin-1 suppresses interleukin-1β-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats. Aging. 2020;12(2):1760–1777. doi:10.18632/aging.102711
  • Tang C, Fu X, Xu X, Wei X, Pan H. The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides. 2012;36(1):39–45. doi:10.1016/j.peptides.2012.04.014
  • Özsavcí D, Erşahin M, Şener A, et al. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery. 2011;68(6):1699–1708; discussion 1708. doi:10.1227/NEU.0b013e318210f258
  • Arnett F, Edworthy S, Bloch D, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/art.1780310302
  • Kay J, Upchurch K. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology. 2012;51(suppl_6):vi5–9. doi:10.1093/rheumatology/kes279
  • Goronzy J, Weyand C. Immune aging and autoimmunity. Cell Mol Life Sci. 2012;69(10):1615–1623. doi:10.1007/s00018-012-0970-0
  • Kato E, Sawada T, Tahara K, et al. The age at onset of rheumatoid arthritis is increasing in Japan: a nationwide database study. Int J Rheum Dis. 2017;20(7):839–845. doi:10.1111/1756-185x.12998
  • Kremers H, Myasoedova E, Crowson C, Savova G, Gabriel S, Matteson E. The Rochester epidemiology project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology. 2011;50(1):6–15. doi:10.1093/rheumatology/keq199
  • van Schaardenburg D, Breedveld F. Elderly-onset rheumatoid arthritis. Semin Arthritis Rheum. 1994;23(6):367–378. doi:10.1016/0049-0172(94)90087-6
  • Baker J, Billig E, Michaud K, et al. Weight loss, the obesity paradox, and the risk of death in rheumatoid arthritis. Arthritis Rheumatol. 2015;67(7):1711–1717. doi:10.1002/art.39136
  • Tański W, Wójciga J, Jankowska-Polańska B. Association between malnutrition and quality of life in elderly patients with rheumatoid arthritis. Nutrients. 2021;13(4):1259. doi:10.3390/nu13041259
  • Schalla M, Unniappan S, Lambrecht N, Mori M, Taché Y, Stengel A. NUCB2/nesfatin-1 - Inhibitory effects on food intake, body weight and metabolism. Peptides. 2020;128:170308. doi:10.1016/j.peptides.2020.170308
  • Shimizu M, Manome T, Kumami M, et al. Detection of NUCB2/nesfatin-1 in cerebrospinal fluid of multiple sclerosis patients. Aging. 2020;12(23):24134–24140. doi:10.18632/aging.202287
  • Dai H, Li X, He T, et al. Decreased plasma nesfatin-1 levels in patients with acute myocardial infarction. Peptides. 2013;46:167–171. doi:10.1016/j.peptides.2013.06.006
  • Catak Z, Yavuzkir S, Kocdemir E, et al. NUCB2/nesfatin-1 in the blood and follicular fluid in patients with polycystic ovary syndrome and poor ovarian response. J Reprod Infertil. 2019;20:225–230.
  • Aletaha D, Alasti F, Smolen J. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis Res Ther. 2015;17(1):229. doi:10.1186/s13075-015-0736-9
  • Sokolove J, Johnson D, Lahey L, et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(4):813–821. doi:10.1002/art.38307
  • Kvlividze T, Zavodovsky B, Akhverdyan Y, et al. Serum nesfatin-1 as a marker of systemic inflammation in rheumatoid arthritis. Klin Lab Diagn. 2019;64:53–56. doi:10.18821/0869-2084-2019-64-1-53-56
  • Kim G, Lee N, Pi R, et al. IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future. Arch Pharm Res. 2015;38(5):575–584. doi:10.1007/s12272-015-0569-8
  • Feldmann M, Brennan F, Foxwell B, Maini R. The role of TNF alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun. 2001;3:188–199. doi:10.1159/000060522
  • Wang D, Li Y, Liu Y, Shi G. The use of biologic therapies in the treatment of rheumatoid arthritis. Curr Pharm Biotechnol. 2014;15(6):542–548. doi:10.2174/138920101506140910150612
  • Xia Q, Liang J, Cao Y, Shan F, Liu Y, Xu Y. Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder. Clin Chim Acta. 2018;480:107–111. doi:10.1016/j.cca.2018.02.004
  • Jiang L, Bao J, Zhou X, Xiong Y, Wu L. Increased serum levels and chondrocyte expression of nesfatin-1 in patients with osteoarthritis and its relation with BMI, hsCRP, and IL-18. Mediators Inflamm. 2013;2013:631251. doi:10.1155/2013/631251
  • Pahlitzsch M, Fritsche-Guenther R, Pompös I, et al. Correlation of NUCB2/nesfatin-1 with cytokine levels in primary open-angle glaucoma. Clinical Ophthalmol. 2021;15:2505–2517. doi:10.2147/opth.s307379
  • Loosen S, Koch A, Tacke F, Roderburg C, Luedde T. The role of adipokines as circulating biomarkers in critical illness and sepsis. Int J Mol Sci. 2019;20(19):4820. doi:10.3390/ijms20194820
  • Su X, Peng D. Adipokines as novel biomarkers of cardio-metabolic disorders. Clin Chim Acta. 2020;507:31–38. doi:10.1016/j.cca.2020.04.009
  • Wang X, Zheng Y, Fang P, Song X. Nesfatin-1 is a potential diagnostic biomarker for gastric cancer. Oncol Lett. 2020;19:1577–1583. doi:10.3892/ol.2019.11200
  • Xu Y, Ge J, Liang J, et al. Nesfatin-1 and cortisol: potential novel diagnostic biomarkers in moderate and severe depressive disorder. Psychol Res Behav Manag. 2018;11:495–502. doi:10.2147/prbm.s183126
  • Pałasz A, Krzystanek M, Worthington J, et al. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides. 2012;46(3):105–112. doi:10.1016/j.npep.2011.12.002
  • Lee B, Song Y, Rhodes C, et al. Protein phosphatase magnesium-dependent 1A induces inflammation in rheumatoid arthritis. Biochem Biophys Res Commun. 2020;522(3):731–735. doi:10.1016/j.bbrc.2019.11.112
  • Pousinis P, Gowler P, Burston J, Ortori C, Chapman V, Barrett D. Lipidomic identification of plasma lipids associated with pain behaviour and pathology in a mouse model of osteoarthritis. Metabolomics. 2020;16(3):32. doi:10.1007/s11306-020-01652-8